Search research articles
Contact Us
Filters
Showing results (61-70 of 72) with videos related to
Page
of 8
Sort By:
Biorxiv : the Preprint Server for Biology
|
May 7, 2026
Linking human brain functional connectivity to underlying neurotransmission
Leon D Lotter, Golia Shafiei, Daouia Larabi, et al.
Psychiatric Genetics
|
September 10, 2002
Genetic polymorphisms and cerebrospinal fluid levels of tissue inhibitor of metalloproteinases 1 in sporadic Alzheimer's disease
M Axel Wollmer, Andreas Papassotiropoulos, Johannes R Streffer, et al.
Journal of Psychopharmacology (Oxford, England)
|
October 16, 2025
A novel psychedelic 5-HT<sub>2A</sub> receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer
Gerard J Marek, Soma Makai-Bölöni, Daniel Umbricht, et al.
Neuroscience Applied
|
August 21, 2025
Using the grip strength effort task to measure reward processing dysfunction in schizophrenia and major depressive disorder
Asad Malik, Shannon N Millard, Ailidh Finlayson, et al.
Frontiers in Neurology
|
October 18, 2021
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data
Gennaro Pagano, Frank G Boess, Kirsten I Taylor, et al.
Scientific Reports
|
March 8, 2018
Cerebral blood flow predicts differential neurotransmitter activity
Juergen Dukart, Štefan Holiga, Christopher Chatham, et al.
Schizophrenia Research
|
September 14, 2013
Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia
Stephen R Marder, Larry Alphs, Ion-George Anghelescu, et al.
The New England Journal of Medicine
|
August 3, 2022
Trial of Prasinezumab in Early-Stage Parkinson's Disease
Gennaro Pagano, Kirsten I Taylor, Judith Anzures-Cabrera, et al.
The American Journal of Psychiatry
|
December 7, 2016
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
Oliver D Howes, Rob McCutcheon, Ofer Agid, et al.
The American Journal of Psychiatry
|
October 8, 2025
Relapse in Schizophrenia: A Systematic Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve Them
Oliver D Howes, Bernard R Bukala, Eric Y H Chen, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 72) with videos related to
Sort By:
Page
of 8
Biorxiv : the Preprint Server for Biology
|
May 7, 2026
Linking human brain functional connectivity to underlying neurotransmission
Leon D Lotter, Golia Shafiei, Daouia Larabi, et al.
Psychiatric Genetics
|
September 10, 2002
Genetic polymorphisms and cerebrospinal fluid levels of tissue inhibitor of metalloproteinases 1 in sporadic Alzheimer's disease
M Axel Wollmer, Andreas Papassotiropoulos, Johannes R Streffer, et al.
Journal of Psychopharmacology (Oxford, England)
|
October 16, 2025
A novel psychedelic 5-HT<sub>2A</sub> receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer
Gerard J Marek, Soma Makai-Bölöni, Daniel Umbricht, et al.
Neuroscience Applied
|
August 21, 2025
Using the grip strength effort task to measure reward processing dysfunction in schizophrenia and major depressive disorder
Asad Malik, Shannon N Millard, Ailidh Finlayson, et al.
Frontiers in Neurology
|
October 18, 2021
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data
Gennaro Pagano, Frank G Boess, Kirsten I Taylor, et al.
Scientific Reports
|
March 8, 2018
Cerebral blood flow predicts differential neurotransmitter activity
Juergen Dukart, Štefan Holiga, Christopher Chatham, et al.
Schizophrenia Research
|
September 14, 2013
Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia
Stephen R Marder, Larry Alphs, Ion-George Anghelescu, et al.
The New England Journal of Medicine
|
August 3, 2022
Trial of Prasinezumab in Early-Stage Parkinson's Disease
Gennaro Pagano, Kirsten I Taylor, Judith Anzures-Cabrera, et al.
The American Journal of Psychiatry
|
December 7, 2016
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
Oliver D Howes, Rob McCutcheon, Ofer Agid, et al.
The American Journal of Psychiatry
|
October 8, 2025
Relapse in Schizophrenia: A Systematic Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve Them
Oliver D Howes, Bernard R Bukala, Eric Y H Chen, et al.
Page
of 8